Book Review: Chokepoint Capitalism: How Big Tech and Big Content Captured Creative Labor Markets and How We’ll Win Them Back, by Rebecca Giblin and Cory Doctorow. Boston: Beason Press, 2022. 303 pp. $26.95. Rebecca Giblin holds a Bachelor of Laws degree and a PhD, both from Monash University in Melbourne, Australia. She is currently a […]
Can money buy better health? Not directly, maybe—yet research findings suggest that Americans with the highest income rates are also more likely to report better health status and achieve a longer life expectancy compared to low-income families. How pronounced is the difference in health outcomes between the ultra-wealthy and the rest of us? What factors […]
Is the supplement industry stealing business from pharmaceutical companies? To better understand the competition and connections between these industries, we looked at market size and growth, the results of scientific research, and current trends and future projections in the pharmaceutical and supplement industries.
There are always opportunities for the pharmaceutical industry to do more—whether that means boosting value for shareholders, improving access to much-needed medicines in emerging markets around the world, or developing cutting-edge new drugs to cure, treat, manage, or prevent serious medical conditions.
With these opportunities in mind, we asked a simple question with complex answers: how can the pharmaceutical industry be improved?